Guidance for industry
Subtitle: addendum to "Dose selection for carcinogenicity studies of pharmaceuticals" : addition of a limit dose and related notes ICH topic S1C(R)
Contributors: Canada. Therapeutic Products Programme.
Series: Therapeutic Products Programme; Therapeutic Products Programme guideline
Publisher: Therapeutic Products Programme, Health Canada
Published: 2000
Place of publication: Ottawa, Ont
Language: eng
Format: Electronic resource
Subjects: Drugs -- Testing -- Standards -- Canada.; Carcinogenicity testing -- Canada.
Notes: Issued also in French under title: Ligne directrice à l'intention de l'industrie.  Annexe à "Sélection des doses pour les études de carcinogénicité des produits pharmaceutiques", ajout d'une dose limite avec remarques ICH thème S1C(R).

1